BEATRICE MUMA: Open Payments
NPI 1972079879 · HANOVER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,149 in 98 payments from 28 companies in 2025. Trend: 2023 $2,209 · 2024 $2,130 · 2025 $2,149
Food & beverage: $2,139Education: $10
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $289 |
| Sumitomo Pharma America, Inc. | 11 | $235 |
| Ferring Pharmaceuticals Inc. | 14 | $206 |
| ABBVIE INC. | 9 | $194 |
| Janssen Biotech, Inc. | 9 | $166 |
| IMMUNITYBIO, INC. | 1 | $135 |
| Endo USA, Inc. | 6 | $106 |
| Merck Sharp & Dohme LLC | 4 | $84 |
| Astellas Pharma US Inc | 3 | $79 |
| PFIZER INC. | 4 | $72 |
Products named: Nubeqa, ADSTILADRIN, ERLEADA, GEMTESA, BOTOX, ANKTIVA, Xtandi, AVEED.
Industry payments across MD — which companies pay providers there.
